Allarity Therapeutics Inc. (NASDAQ: ALLR)
$0.20
+0.0040 ( +2.04% ) 3.0M
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Market Data
Open
$0.20
Previous close
$0.20
Volume
3.0M
Market cap
$5.09M
Day range
$0.18 - $0.20
52 week range
$0.18 - $69.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 4 | Jan 26, 2024 |
8-k | 8K-related | 13 | Jan 25, 2024 |
8-k | 8K-related | 15 | Jan 19, 2024 |
8-k | 8K-related | 12 | Dec 11, 2023 |
8-k | 8K-related | 58 | Dec 06, 2023 |
8-k | 8K-related | 14 | Dec 05, 2023 |
8-k | 8K-related | 12 | Nov 17, 2023 |
10-q | Quarterly Reports | 83 | Nov 14, 2023 |
8-k | 8K-related | 55 | Nov 13, 2023 |
8-k | 8K-related | 12 | Oct 30, 2023 |